ORTINLAB

ORTINLAB

Pharmaceuticals & Drugs

19.7

0.00 (0.00%)

stock change
Market Cap16 CrEPS-1.0High20.3
Stock P/E0.0Net Profit Margin-421.4Low19.7
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
explain

Performance

Today’s Low

Today’s High

19.7

20.3

52W Low

52W High

16.2

30.35

Open Price19.85Volume417
Prev. Close19.85
explain

Fundamentals

explain
Market Cap16 CrROE-0.9%
P/E Ratio(TTM)0.0EPS(TTM)0.0
P/B Ratio1.6Dividend Yield0.0%
Industry P/E40.0Book Value12.0
Face Value10.0
explain

About the Company

Ortin Laboratories established in the year 1986  was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Quality is the hallmark of Ortin. At every stage of production from raw material to finished products, highest standard of quality is ensured with the help of most modern equipment and experienced personnel.This unflinching perseverance towards quality has helped the company to earn enormous goodwill & trust, both from medical profession and pharmaceutical trade.

Being in partnership with the world means respecting its resources without compromise and so at Ortin, continuous process evaluation and monitoring waste recoveries ensure that the focus is maintained. Specialized facilities have helped us to earn a reputation for the expert handling of hazardous materials in the form of reactants and products. Teams from the ministry of health regularly inspect the company's plant. Every care is taken for treatment of solid wasters, discharged liquids and atmospheric releases.

Ortin is contemplating an entry into the OTC segment as part of its long term growth strategy. It is channeling its efforts towards building an overseas marketing network in order to enhance exports to third world countries. Ortin proposes to be certified as a WHO GMP Unit and to launch innovative Biotechnology products in Orthopedic and Dental Segments. The success behind them is only the Reliance which they carry for their Quality from the people all over the country. Their motto, right from their inception has been towards Quality and they still maintain them and continue to do so in future.

Products manufactured by the company include:

  • Capsules
  • Syrups / Dry syrups
  • Powders
  • Second Division Products
  • Generic Products

Achievements/ recognition :

  • Ortin has been certified as an ISO 9001: 2000 company by the internationally recognized Quality Management Certification Body, the National Quality Assurance, UK in pursuance of its focus towards Quality with its Policy to enhance customer satisfaction by providing Quality Pharmaceutical Formulations at optimum cost and maintain profitability through continual improvement of Quality Management Sytems and cGMP.
  • Ortin is honored as a registered Supplier of Drugs & Medicines with the most reputed Central, State & Quasi-Government Organizations & Institutions of our Country such as the Railways, Health Ministry, Defence, Posts & Telegraph, Electricity Hospitals, Transport Organizations, Research Institutions such as JIPMER, IICT etc.
Parent OrganizationOrtin Laboratories Ltd.Managing DirectorS Murali Krishna Murthy
Founded1986NSE SymbolORTINLAB
explain

Financials

All values are in Rs Cr

explain

Shareholding Pattern

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

explain

Peer Comparison

Company52 WeekMarket PriceP/E RatioFinancialsShare Holding
19.7(-0.8%)
0.0
2.9(0.0%)
0.0
5.3(0.0%)
0.0
67.5(-0.4%)
10.3
explain

Recently Viewed

No Recently Viewed Stocks
explain

Frequently asked questions

You can buy the shares of Ortin Laboratories using the Trinkerr Website or by downloading the Trinkerr app from Android and Apptore.